Loading organizations...
UpStart Life Sciences Capital, L.P. is a venture capital fund focusing on seed and early-stage healthcare companies. It invests in breakthrough technologies from major research universities, primarily in Utah and neighboring states. The fund actively forms and manages ventures across medical devices, drug delivery, diagnostics, and biopharma, cultivating value.
Managing Directors Steve Borst and Dennis Farrar established UpStart in 2009. Leveraging deep experience operating venture-funded life science companies, their insight addressed an underserved niche in early-stage investing for university spin-outs in the Mountain West, capitalizing on their proven track record.
UpStart partners with promising early-stage life science ventures, offering capital and strategic guidance for disruptive technologies. Its vision fosters innovation through collaboration with academic institutions, deploying capital efficiently, supporting development in university labs. This translates research into viable commercial entities, advancing medical treatments.
UpStart Life Sciences Capital has 1 tracked investment across 1 company. The latest tracked deal is $19.0M Series A in Sera Prognostics in November 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2011 | Sera Prognostics | $19.0M Series A | Domain Associates, Joshua Phillips, Doug Fisher | Adjuvant Capital, Alta Partners, InterWest, LUX Capital, Forest Baskett, Osage University Partners |